CN Patent

CN119431398A — R406及其衍生物协同trail的抗肿瘤应用

Assigned to Shanghai Institute of Organic Chemistry of CAS · Expires 2025-02-14 · 1y expired

What this patent protects

本发明提供了一系列具有如式(I)所示通式的化合物、其药学上可接受的盐、水合物或溶剂化物，以及其与TRAIL联合用药在治疗肿瘤或抑制肿瘤细胞中的用途。本发明的药物组合用于抗肿瘤，具有安全性好、耐受性强、敏感性高等特点，十分适合用于抗肿瘤药物的开发。

USPTO Abstract

本发明提供了一系列具有如式(I)所示通式的化合物、其药学上可接受的盐、水合物或溶剂化物，以及其与TRAIL联合用药在治疗肿瘤或抑制肿瘤细胞中的用途。本发明的药物组合用于抗肿瘤，具有安全性好、耐受性强、敏感性高等特点，十分适合用于抗肿瘤药物的开发。

Drugs covered by this patent

Patent Metadata

Patent number
CN119431398A
Jurisdiction
CN
Classification
—
Expires
2025-02-14
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Institute of Organic Chemistry of CAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.